Neurocrine Biosciences | 债务

Debt 更改 日
AbbVie USD 74B 13.26B 2024-03
Acadia Pharmaceuticals USD 59.64M 59.64M 2024-03
Agios Pharmaceuticals USD 68.35M 67.21M 2024-03
ALKERMES USD 370.11M 79.38M 2024-03
Alnylam Pharmaceuticals USD 1.3B 280.46M 2024-03
Amgen USD 64.02B 593M 2024-03
Biogen USD 6.95B 8.4M 2024-03
BioMarin Pharmaceutical USD 1.1B 9.56M 2024-03
Cytokinetics USD 754.92M 136.46M 2024-03
Dynavax Technologies USD 251.54M 28.84M 2024-03
Exelixis USD 201.47M 201.47M 2024-03
Gilead Sciences USD 25.19B 212M 2024-03
Halozyme Therapeutics USD 1.5B 1.63M 2024-03
Incyte USD 37.39M 4.79M 2024-03
Intra Cellular Therapies USD 16.38M 16.38M 2024-03
Ionis Pharmaceuticals USD 1.44B 169.41M 2024-03
Neurocrine Biosciences USD 511.9M 342M 2024-03
Pfizer USD 68.71B 5.11B 2024-03
Prothena USD 12.5M 12.5M 2024-03
Regeneron Pharmaceuticals USD 2.7B 400K 2024-03
Repligen USD 737.73M 451.77M 2024-03
Sarepta Therapeutics USD 1.38B 142.59M 2024-03
Teva Pharmaceutical Industries USD 19.94B 105M 2024-03
Ultragenyx Pharmaceutical USD 40.76M 40.76M 2024-03
Vertex Pharmaceuticals USD 721.3M 331M 2024-03



Neurocrine Biosciences 债务 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.